Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-24 @ 5:24 PM
NCT ID:
NCT04711850
Eligibility Criteria:
Inclusion Criteria:
* Signed Informed Consent obtained before any trial-related procedures
* Willingness and ability to comply with the protocol
* Previous treatment with imlifidase or plasma exchange in the trial 16-HMedIdeS-12
Note: The primary objective of this trial is overall graft survival after treatment with imlifidase or plasma exchange. Therefore, subjects can also be included even if the subject did not fully complete the feeder trial follow up but was dosed with imlifidase or plasma exchange in the trial 16-HMedIdeS-12.
Exclusion Criteria:
• Inability by the judgement of the investigator to participate in the trial for any other reason
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04711850
Study Brief:
Protocol Section:
NCT04711850